Intensity Therapeutics, Inc.
INTS · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $10,446 | $5,793 | $29,891 | $25,745 |
| - Cash | $7,067 | $2,216 | $929 | $2,590 |
| + Debt | $118 | $125 | $131 | $138 |
| Enterprise Value | $3,497 | $3,702 | $29,093 | $23,293 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | $62 | -$2,705 | -$3,394 | -$3,181 |
| % Margin | – | – | – | – |
| Net Income | -$2,671 | -$2,537 | -$3,347 | -$3,181 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.06 | -0.13 | -0.22 | -0.22 |
| % Growth | 53.8% | 40.9% | 0% | – |
| Operating Cash Flow | -$2,387 | -$2,456 | -$1,989 | -$2,668 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$2,387 | -$2,456 | -$1,989 | -$2,668 |